260 related articles for article (PubMed ID: 28516512)
1. Defective α
Mitchell JL; Wright S; Kazi S; Watson HG; Mutch NJ
Br J Haematol; 2017 Sep; 178(5):794-799. PubMed ID: 28516512
[TBL] [Abstract][Full Text] [Related]
2. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
Beckman JD; Holle LA; Wolberg AS
J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
[TBL] [Abstract][Full Text] [Related]
3. Relevant bleeding diathesis due to acquired factor XIII deficiency.
Janning M; Holstein K; Spath B; Schnabel C; Bannas P; Bokemeyer C; Langer F
Hamostaseologie; 2013; 33 Suppl 1():S50-4. PubMed ID: 24169946
[TBL] [Abstract][Full Text] [Related]
4. A case of acquired FXIII deficiency with severe bleeding symptoms.
Hayashi T; Kadohira Y; Morishita E; Asakura H; Souri M; Ichinose A
Haemophilia; 2012 Jul; 18(4):618-20. PubMed ID: 22356719
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
Zabczyk M; Natorska J; Bagoly Z; Sarkady F; Barath B; Katona E; Bryk A; Zettl K; Wisniewski JR; Undas A
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33214340
[TBL] [Abstract][Full Text] [Related]
6. Measurement of factor XIII activity in plasma.
Katona É; Pénzes K; Molnár É; Muszbek L
Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
[TBL] [Abstract][Full Text] [Related]
7. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
[TBL] [Abstract][Full Text] [Related]
8. Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism.
Ogawa Y; Yanagisawa K; Souri M; Mihara M; Naito C; Takizawa M; Ishizaki T; Mitsui T; Handa H; Osaki T; Nojima Y; Ichinose A
Acta Haematol; 2017; 137(3):141-147. PubMed ID: 28380473
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
[TBL] [Abstract][Full Text] [Related]
10. Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies.
Ichinose A; Osaki T; Souri M
Haemophilia; 2021 May; 27(3):454-462. PubMed ID: 33847063
[TBL] [Abstract][Full Text] [Related]
11. Reduced difference of α₂-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies.
Ichinose A; Souri M
Int J Hematol; 2012 Jan; 95(1):47-50. PubMed ID: 22205503
[TBL] [Abstract][Full Text] [Related]
12. Minimal factor XIII activity level to prevent major spontaneous bleeds.
Menegatti M; Palla R; Boscarino M; Bucciarelli P; Muszbek L; Katona E; Makris M; Peyvandi F;
J Thromb Haemost; 2017 Sep; 15(9):1728-1736. PubMed ID: 28688221
[TBL] [Abstract][Full Text] [Related]
13. Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage.
Chuliber FA; Schutz NP; Viñuales ES; Penchasky DL; Otero V; Villagra Iturre MJ; López MS; Mezzarobba D; Barrera LH; Privitera V; Arbelbide JA; Martinuzzo ME
Blood Coagul Fibrinolysis; 2020 Dec; 31(8):511-516. PubMed ID: 32852328
[TBL] [Abstract][Full Text] [Related]
14. The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.
Fraser SR; Booth NA; Mutch NJ
Blood; 2011 Jun; 117(23):6371-4. PubMed ID: 21471521
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Factor XIII.
Muszbek L; Katona É; Kerényi A
Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune acquired coagulation factor XIII/13 deficiency caused by type Ab anti-FXIII-A autoantibody].
Kadono M; Souri M; Shimomura T; Kuroda Y; Munemasa S; Ozaki T; Ichinose A
Rinsho Ketsueki; 2023; 64(12):1508-1513. PubMed ID: 38220150
[TBL] [Abstract][Full Text] [Related]
17. Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Ghansah H; Orbán-Kálmándi R; Debreceni IB; Katona É; Rejtő L; Váróczy L; Lóczi L; de Laat B; Huskens D; Kappelmayer J; Bagoly Z
Thromb Res; 2024 Feb; 234():12-20. PubMed ID: 38134612
[TBL] [Abstract][Full Text] [Related]
18. Factor XIII deficiency.
Hsieh L; Nugent D
Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
[TBL] [Abstract][Full Text] [Related]
19. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.
Shaya SA; Gani DM; Weitz JI; Kim PY; Gross PL
Thromb Haemost; 2019 Jun; 119(6):992-999. PubMed ID: 31005064
[TBL] [Abstract][Full Text] [Related]
20. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
van Giezen JJ; Minkema J; Bouma BN; Jansen JW
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
